News EPFL

Our brains have a “fingerprint” too

Published:18.10.21 — An EPFL scientist has pinpointed the signs of brain activity that make up our brain fingerprint, which – like our regular fingerprint – is unique.

New nanowire architectures boost computers' processing power

Published:15.10.21 — Valerio Piazza is creating new 3D architectures built from an inventive form of nanowire. His research aims to push the boundaries of miniaturization and pave the way to more powerful electronic devices. He has just won the 2020 Piaget Scientific Award, whose prize money will fund his work at EPFL for a year.

Social media and AI can measure the aesthetic quality of landscapes

Published:15.10.21 — To measure an ecosystem’s beauty and the well-being it produces for people can help inform public environmental policy. Scientists at EPFL and Wageningen University in the Netherlands have developed a novel modeling approach for ecosystem assessments based on deep learning and millions of Flickr photos.

New proteins enable scientists to control cell activities

Published:14.10.21 — EPFL scientists have developed new controlled proteins and used to switch cellular activities on and off like a light bulb.

How to force photons to never bounce back

Published:13.10.21 — EPFL scientists have developed a topology-based method that forces microwave photons to travel along a one way path, despite unprecedented levels of disorder and obstacles on their way. This discovery paves the way to a new generation of high-frequency circuits and extremely robust, compact communication devices.

EPFL is acting on harassment

Published:13.10.21 — EPFL has adopted a series of prevention, support and follow-up measures that were recommended by the School’s Harassment Task Force. In a recent survey of the EPFL community, 80% of respondents indicated that they were satisfied with the overall climate on campus but that improvements were needed in terms of safety, equality and efforts to fight discrimination.

Scientists discover a highly potent antibody against SARS-CoV-2

Published:12.10.21 — Scientists at Lausanne University Hospital (CHUV) and EPFL have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified to date, including the delta variant. Their findings are published in the prestigious journal Cell Reports.